{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T13:01:48Z","timestamp":1785589308553,"version":"3.56.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1985,8,1]],"date-time":"1985-08-01T00:00:00Z","timestamp":491702400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatr Neurol Sci"],"published-print":{"date-parts":[[1985,8]]},"DOI":"10.1007\/bf00380972","type":"journal-article","created":{"date-parts":[[2004,11,7]],"date-time":"2004-11-07T04:57:44Z","timestamp":1099803464000},"page":"60-64","source":"Crossref","is-referenced-by-count":101,"title":["Treatment of drug-induced exogenous psychosis in Parkinsonism with clozapine and fluperlapine"],"prefix":"10.1007","volume":"235","author":[{"given":"E.","family":"Scholz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Dichgans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","first-page":"923","volume-title":"Psychotherapeutic drugs, vol 2, part 2","author":"M Ackenheil","year":"1977","unstructured":"Ackenheil M, Hippius H (1977) Clozapine. In: Usdin E, Forrest I (ed) Psychotherapeutic drugs, vol 2, part 2. Marcel Dekker Inc, New York Basel, pp 923?956"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.2042-7158.1973.tb10025.x","volume":"25","author":"NE And\u00e9n","year":"1973","unstructured":"And\u00e9n NE, Stuck G (1973) Effect of clozapine on the turn-over of dopamine in the corpus striatum and in the limbic system. J Pharm Pharmacol 25:346?348","journal-title":"J Pharm Pharmacol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF00606410","volume":"11","author":"B Andermann","year":"1977","unstructured":"Andermann B, Griffith RW (1977) Clozapine-induced agranulocytosis: A situation report up to August 1976. Eur J Clin Pharmacol 11:199?201","journal-title":"Eur J Clin Pharmacol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1001\/archneur.1980.00500520053008","volume":"37","author":"BL Beasley","year":"1980","unstructured":"Beasley BL, Nutt JG, Davenport RW, Chase TN (1980) Treatment with Tryptophan of levodopa-associated psychiatric disturbances. Arch Neurol 37:155?156","journal-title":"Arch Neurol"},{"key":"CR5","first-page":"128","volume":"23","author":"W Birkmayer","year":"1966","unstructured":"Birkmayer W (1966) Experimentelle Befunde und neue Aspekte bei extrapyramidalen Erkrankungen. Wien Z Nervenheilkunde 23:128?139","journal-title":"Wien Z Nervenheilkunde"},{"key":"CR6","first-page":"76","volume":"43","author":"W Birkmayer","year":"1972","unstructured":"Birkmayer W, Neumayer E (1972) Die Behandlung der Dopa-Psychosen mit L-Tryptophan. Nervenarzt 43:76?78","journal-title":"Nervenarzt"},{"key":"CR7","first-page":"499","volume":"24","author":"W Birkmayer","year":"1979","unstructured":"Birkmayer W, Riederer P, Rausch WD (1979) Neuropharmacological principles and problems of combined L-Dopa treatment in Parkinson's disease. Adv Neurol 24:499?510","journal-title":"Adv Neurol"},{"key":"CR8","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-7091-2253-2","volume-title":"Die Parkinson-Krankheit. Biochemie, Klinik, Therapie","author":"W Birkmayer","year":"1980","unstructured":"Birkmayer W, Riederer P (1980) Die Parkinson-Krankheit. Biochemie, Klinik, Therapie. Springer, Wien, New York"},{"key":"CR9","first-page":"87","volume-title":"Perspektiven der Schizophrenie-Forschung","author":"S Bischoff","year":"1985","unstructured":"Bischoff S, Delini-Stula A, Maitre L (1985) Blockade der Dopamin-Rezeptoren im Hippokampus als Indikator antipsychotischer Wirksamkeit: Korrelationen zwischen neurochemischen und psychopharmakologischen Wirkungen von Neuroleptika. In: Pflug B, Foerster K, Straube E (Hrsg) Perspektiven der Schizophrenie-Forschung. Gustav Fischer, Stuttgart New York, S 87?103"},{"key":"CR10","first-page":"357","volume-title":"Lisuride and other dopamine agonists","author":"DB Caine","year":"1983","unstructured":"Caine DB (1983) Ergot derivates and extrapyramidal disease. In: Caine DB, Horowski R, McDonald RJ, Wuttke W (eds) Lisuride and other dopamine agonists. Raven Press, New York, pp 357?361"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1176\/ajp.135.2.164","volume":"135","author":"A Carlsson","year":"1978","unstructured":"Carlsson A (1978) Antipsychotic drugs, neurotransmitters, and schizophrenia. Am J Psychiatry 135:164?173","journal-title":"Am J Psychiatry"},{"key":"CR12","first-page":"110","volume":"34","author":"E Eichenberger","year":"1984","unstructured":"Eichenberger E (1984) Pharmacology of Fluperlapine compared with Clozapine. Arzneim Forsch\/Drug Res 34:110?113","journal-title":"Arzneim Forsch\/Drug Res"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1055\/s-0028-1107783","volume":"99","author":"W Gehlen","year":"1974","unstructured":"Gehlen W, M\u00fcller J (1974) Zur Therapie der Dopa-Psychosen mit L-Tryptophan. Dtsch Med Wochenschr 99:457?463","journal-title":"Dtsch Med Wochenschr"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1600-0447.1974.tb09706.x","volume":"50","author":"J Gerlach","year":"1974","unstructured":"Gerlach J, Koppelhus P, Helweg E, Monrad A (1974) Clozapine and Haloperidol in a single-blind cross-over trial: therapeutic and biochemical aspects in the treatment of schizophrenia. Acta Psychiatr Scand 50:410?424","journal-title":"Acta Psychiatr Scand"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1176\/ajp.139.11.1526","volume":"139","author":"CG Goetz","year":"1982","unstructured":"Goetz CG, Tanner CM, Klawans HL (1982) Pharmacology of hallucinations induced by long-term drug therapy. Am J Psychiatry 139:494?497","journal-title":"Am J Psychiatry"},{"key":"CR16","first-page":"251","volume":"1","author":"E Halgren","year":"1982","unstructured":"Halgren E (1982) Mental phenomena induced by stimulation in the limbic system. Human Neurobiol 1:251?260","journal-title":"Human Neurobiol"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"MM Hoehn","year":"1967","unstructured":"Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression, and mortality. Neurology 17:427?442","journal-title":"Neurology"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF00606409","volume":"11","author":"J Id\u00e4np\u00e4\u00e4n-Heikkil\u00e4","year":"1977","unstructured":"Id\u00e4np\u00e4\u00e4n-Heikkil\u00e4 J, Alhava E, Olkinnora M, Palva IP (1977) Agranulocytosis during treatment with Clozapine. Eur J Clin Pharmacol 11:193?198","journal-title":"Eur J Clin Pharmacol"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/BF00432029","volume":"84","author":"S Korsgaard","year":"1984","unstructured":"Korsgaard S, Noring U, Gerlach J (1984) Fluperlapine in tardive dyskinesia and parkinsonism. Psychopharmacology 84:76?79","journal-title":"Psychopharmacology"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1212\/WNL.29.9_Part_1.1253","volume":"29","author":"RP Lesser","year":"1979","unstructured":"Lesser RP, Fahn S, Snider SR, Cote LJ, Isgreen WP, Barrett RE (1979) Analysis of the clinical problems in parkinsonism and the complications of long-term levodopa therapy. Neurology 29:1253?1260","journal-title":"Neurology"},{"key":"CR21","first-page":"245","volume-title":"Ergot compounds and brain function: Neuroendocrine and neuropsychiatric aspects","author":"A Lieberman","year":"1980","unstructured":"Lieberman A, Kupersmith M, Neophytides A (1980) Bromocriptine in Parkinson's disease: report on 106 patients treated up to 5 years. In: Caine DB, Goldstein M, Lieberman A, Thorner M (eds) Ergot compounds and brain function: Neuroendocrine and neuropsychiatric aspects. Raven Press, New York, pp 245?253"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1212\/WNL.31.6.675","volume":"31","author":"A Lieberman","year":"1981","unstructured":"Lieberman A, Goldstein M, Leibowitz M, Neophytides A, Kupersmith M, Pact V, Kleinberg D (1981) Treatment of advanced Parkinson's disease with pergolide. Neurology 31:675?682","journal-title":"Neurology"},{"key":"CR23","first-page":"1","volume-title":"Movement disorders","author":"CD Marsden","year":"1981","unstructured":"Marsden CD, Fahn S (1981) Problems in Parkinson's disease. In: Marsden CD, Fahn S (eds) Movement disorders. Butterworth Scientific, London, pp 1?7"},{"key":"CR24","first-page":"218","volume":"135","author":"C Moskovitz","year":"1978","unstructured":"Moskovitz C, More H, Klawans H (1978) Levodopa induced psychosis: a kindling phenomenon. Am J Psychiatry 135:218?226","journal-title":"Am J Psychiatry"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1055\/s-2007-1002019","volume":"52","author":"E Schneider","year":"1984","unstructured":"Schneider E, Fischer PA, Jacobi P, Grotz A (1984) Exogene Psychosen beim Parkinsonsyndrom. H\u00e4ufigkeit und Entstehungsbedingungen. Fortschr Neurol Psychiatr 52:207?214","journal-title":"Fortschr Neurol Psychiatr"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1212\/WNL.34.2.201","volume":"34","author":"Y Stern","year":"1984","unstructured":"Stern Y, Mayeux R, Ilson J, Fahn S, Cote L (1984) Pergolide therapy for Parkinson's disease: Neurobehavioural changes. Neurology 34:201?204","journal-title":"Neurology"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1212\/WNL.26.4.305","volume":"26","author":"RD Sweet","year":"1976","unstructured":"Sweet RD, McDowell FH, Feigenson JS, Loranger AW, Goodell H (1976) Mental symptoms in Parkinson's disease during chronic treatment with leveodopa. Neurology 26:305?310","journal-title":"Neurology"},{"key":"CR28","volume-title":"Electroclinical features of the psychomotor seizure","author":"HG Wieser","year":"1983","unstructured":"Wieser HG (1983) Electroclinical features of the psychomotor seizure. Gustav Fischer, Butterworth, Stuttgart New York"},{"key":"CR29","first-page":"122","volume":"34","author":"B Woggon","year":"1984","unstructured":"Woggon B, Heinrich K, K\u00fcfferle B, M\u00fcller-Oerlinghausen B, P\u00f6ldinger W, R\u00fcther E, Schied HW (1984) Results of a multicenter AMDP study with Fluperlapine in schizophrenic patients. Arzneim Forsch\/Drug Res 34:122?124","journal-title":"Arzneim Forsch\/Drug Res"}],"container-title":["European Archives of Psychiatry and Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00380972.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00380972\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00380972","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T21:34:48Z","timestamp":1554327288000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00380972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,8]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1985,8]]}},"alternative-id":["BF00380972"],"URL":"https:\/\/doi.org\/10.1007\/bf00380972","relation":{},"ISSN":["0175-758X","1433-8491"],"issn-type":[{"value":"0175-758X","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,8]]}}}